D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$483M |
| 2 |
Biogen
BIIB
|
+$429M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$397M |
| 4 |
LNKD
LinkedIn Corporation
LNKD
|
+$247M |
| 5 |
Union Pacific
UNP
|
+$242M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$632M |
| 2 |
Marathon Petroleum
MPC
|
+$474M |
| 3 |
Meta Platforms (Facebook)
META
|
+$469M |
| 4 |
DuPont de Nemours
DD
|
+$444M |
| 5 |
Phillips 66
PSX
|
+$444M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.1% |
| 2 | Communication Services | 8.89% |
| 3 | Technology | 8.48% |
| 4 | Energy | 7.71% |
| 5 | Financials | 7.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMGN
1026
DELISTED
Immunogen Inc
IMGN
| $8.5M | 0.01% |
626,129
+122,724
| +24% | +$1.51M |
|
|
FBC
1027
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $8.49M | 0.01% |
367,376
+59,473
| +19% | +$1.37M |
|
1028
Liberty Latin America Class A
LILA
$1.51B
| $8.47M | 0.01% |
319,714
| – | – |
|
1029
CALL
Eastman Chemical
EMN
$7.8B
| $8.47M | 0.01% |
125,400
+43,000
| +52% | +$3.01M |
|
1030
PUT
Cencora
COR
$60.3B
| $8.46M | 0.01% |
81,600
-21,200
| -21% | -$2.08M |
|
|
FL
1031
PUT
DELISTED
Foot Locker
FL
| $8.4M | 0.01% |
129,000
| – | – |
|
1032
CALL
Bread Financial
BFH
$4.21B
| $8.38M | 0.01% |
37,966
| – | – |
|
|
BLT
1033
DELISTED
BLOUNT INTERNATIONAL (NEW)
BLT
| $8.37M | 0.01% |
852,735
+323,027
| +61% | +$2.2M |
|
1034
Crane NXT
CXT
$3.04B
| $8.36M | 0.01% |
503,200
+13,894
| +3% | +$241K |
|
|
BRCM
1035
PUT
DELISTED
BROADCOM CORP CL-A
BRCM
| $8.35M | 0.01% |
144,400
| – | – |
|
1036
CALL
Martin Marietta Materials
MLM
$33.6B
| $8.33M | 0.01% |
61,000
-10,000
| -14% | -$1.52M |
|
1037
Delta Air Lines
DAL
$55.9B
| $8.33M | 0.01% |
164,335
-758,370
| -82% | -$37.5M |
|
1038
Arbutus Biopharma
ABUS
$865M
| $8.33M | 0.01% |
1,871,460
+14,384
| +0.8% | +$78.8K |
|
|
QLGC
1039
DELISTED
QLOGIC CORP
QLGC
| $8.31M | 0.01% |
681,265
+514,537
| +309% | +$6.24M |
|
1040
CALL
NextEra Energy
NEE
$187B
| $8.31M | 0.01% |
320,000
-50,000
| -14% | -$1.27M |
|
1041
British American Tobacco
BTI
$132B
| $8.3M | 0.01% |
150,326
+146,544
| +3,875% | +$8.4M |
|
1042
Deckers Outdoor
DECK
$13.3B
| $8.28M | 0.01% |
1,052,658
-456,294
| -30% | -$4.04M |
|
1043
PUT
Newmont
NEM
$98.2B
| $8.28M | 0.01% |
460,000
-274,600
| -37% | -$5.05M |
|
|
COWN
1044
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $8.24M | 0.01% |
538,013
+77,697
| +17% | +$1.35M |
|
1045
Celanese
CE
$5.09B
| $8.23M | 0.01% |
122,283
-7,725
| -6% | -$525K |
|
|
HAWK
1046
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
| $8.23M | 0.01% |
186,089
-320,751
| -63% | -$14.4M |
|
1047
Conagra Brands
CAG
$7.07B
| $8.22M | 0.01% |
250,603
+115,268
| +85% | +$3.68M |
|
1048
MSC Industrial Direct
MSM
$7.02B
| $8.2M | 0.01% |
145,797
+100,281
| +220% | +$6.06M |
|
1049
PUT
UnitedHealth
UNH
$382B
| $8.2M | 0.01% |
69,700
-52,100
| -43% | -$6.09M |
|
1050
Pacira BioSciences
PCRX
$1.02B
| $8.18M | 0.01% |
106,462
+7,798
| +8% | +$442K |
|
Similar funds
D.E. Shaw & Co's Q4 2015 Portfolio in Review
As of Q4 2015, D.E. Shaw & Co held 4,165 positions worth $67.2B, down 1.1% from $67.9B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.
D.E. Shaw & Co withdrew a net $4.09B in Q4 2015, closing 409 positions and reducing 1,417 holdings. Its most notable exit was Altera Corp, an estimated $236M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Communication Services and Technology.
Against the trend, D.E. Shaw & Co opened a new position in Alphabet (Google) Class A worth $417M.
- D.E. Shaw & Co's largest Q4 2015 buy was Alphabet (Google) Class A: 10,723,880 shares worth $417M.
- D.E. Shaw & Co added most to Apple in Q4 2015, an estimated $483M increase.
- D.E. Shaw & Co's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $632M.
- D.E. Shaw & Co fully exited Altera Corp in Q4 2015, selling an estimated $236M.
- D.E. Shaw & Co's ten largest holdings make up 8.8% of its $67.2B portfolio in Q4 2015.
- D.E. Shaw & Co opened 463 new positions and closed 409 in Q4 2015.
- D.E. Shaw & Co's portfolio value fell 1.1% quarter-over-quarter to $67.2B.
Based on D.E. Shaw & Co's 13F filing for Q4 2015, filed 16 Feb 2016.